Biofrontera AG B8F-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 8:01 AM CET
0.312UNCH (UNCH)
52 week range
0.29 - 1.21
Loading...
  • Open0.312
  • Day High0.312
  • Day Low0.312
  • Prev Close0.348
  • 52 Week High1.21
  • 52 Week High Date04/11/23
  • 52 Week Low0.29
  • 52 Week Low Date03/06/24

Key Stats

  • Market Cap23.62M
  • Shares Out63.81M
  • 10 Day Average Volume6,912.11
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-23.9

KEY STATS

  • Open0.312
  • Day High0.312
  • Day Low0.312
  • Prev Close0.348
  • 52 Week High1.21
  • 52 Week High Date04/11/23
  • 52 Week Low0.29
  • 52 Week Low Date03/06/24
  • Market Cap23.62M
  • Shares Out63.81M
  • 10 Day Average Volume6,912.11
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-23.9

RATIOS/PROFITABILITY

  • EPS (TTM)-0.14
  • P/E (TTM)-2.23
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biofrontera AG

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Biofrontera AG is a Germany-based biopharmaceutical company. The Company develops drugs and medicinal cosmetics for the treatment of skin diseases and regenerative care of damaged skin. Its portfolio includes: Ameluz, for photodynamic therapy (PDT) of actinic keratoses, and under development for other types of skin cancer and warts; PDT lamp BF-RhodoLED, used after the Ameluz treatment to eliminate infected cells; and Belixos, a dermatological cream with herbal ingredients...
Ludwig Lutter
Chief Financial Officer, Member of the Management Board
Address
Hemmelrather Weg 201
Leverkusen
51377
Germany